New search | Conferencedetail
mail
Print view
 
 

iPSC-Derived Cell Therapies Summit

Evvnt Promotion / evvnt
-
07.12.2021 - 09.12.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Conference themes
Innovate The Next Generation of Safe, Scalable and Cost-Effective iPSC-Derived Therapies

The explosion of excitement and investment in the iPSC field has ushered in a new era of cell therapy, with these cells establishing it’s place as the optimal starting material for cell therapies targeting cancer, autoimmune, cardiac disease and much more.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/853667-3?pid=4832

Speakers: Helen Tayton-Martin, CBO, Adaptimmune, Jo Brewer, Head of Allogenic Research, Adaptimmune, Andres Bratt-Leal, Co-Founder, Aspen Neuroscience and more
 

Enquiries and Registration:

https://go.evvnt.com/853667-1?pid=4832
Mr. Customer Services
 
Categories
Clinical Research, General Medicine
Languages
English
Congress fees
USD 1899.00 - USD 3597.00
Participants expected
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Swiss Tropical and Public Health InstituteHelix - Forschung & Beratung WienHilfswerk AustriaAnästhesie in Entwicklungsländern e. V.Österreichisches Rotes KreuzOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Charité International AcademyÄrzte der Welt